Chronic Lymphocytic Leukemia
|
0.070 |
AlteredExpression
|
disease |
BEFREE |
Prior studies revealed that the leukemic B cells of patients with chronic lymphocytic leukemia (CLL) express a restricted Ig heavy chain variable region gene (VH gene) repertoire.
|
8977195 |
1997 |
Chronic Lymphocytic Leukemia
|
0.070 |
AlteredExpression
|
disease |
BEFREE |
Thus, from our present observation of an albeit limited patient population, we have found an association between VH gene family use and CD5 antigen expression in chronic B-cell leukemias.
|
7513207 |
1994 |
Chronic Lymphocytic Leukemia
|
0.070 |
AlteredExpression
|
disease |
BEFREE |
In five of the six unmutated CLLs, the DLBL clones evolved from CLL tumorclones and the VH genes expressed by DLBLs were also unmutated.
|
14671632 |
2004 |
Neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
Differential usage of an Ig heavy chain variable region gene by human B-cell tumors.
|
8324224 |
1993 |
Neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
The immunoglobulin (Ig) heavy chain variable region (VH) gene sequence expressed by the malignant clone in MM can be used as a tumor specific marker.
|
7475288 |
1995 |
Lymphoma, Follicular
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Ig heavy chain variable region (VH) genes expressed by human diffuse large-cell lymphoma (DLC) and follicular lymphoma (FL) were identified and analyzed with respect to germline gene families.
|
7579401 |
1995 |
Multiple Myeloma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
The immunoglobulin (Ig) heavy chain variable region (VH) gene sequence expressed by the malignant clone in MM can be used as a tumor specific marker.
|
7475288 |
1995 |
Diffuse Large B-Cell Lymphoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
In five of the six unmutated CLLs, the DLBL clones evolved from CLL tumorclones and the VH genes expressed by DLBLs were also unmutated.
|
14671632 |
2004 |
Diffuse Large B-Cell Lymphoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Although most of the VH genes expressed by DLC tumor cells contained mutations with respect to their germline counterparts, almost all of these mutations occurred before the clonal expansion of the tumor.
|
7579401 |
1995 |
Teratocarcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The expression of SLC7A4 can be induced in NT2 teratocarcinoma cells by treatment with retinoic acid.
|
12049641 |
2002 |
Adult Diffuse Large Cell Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Although most of the VH genes expressed by DLC tumor cells contained mutations with respect to their germline counterparts, almost all of these mutations occurred before the clonal expansion of the tumor.
|
7579401 |
1995 |
Childhood Diffuse Large Cell Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Although most of the VH genes expressed by DLC tumor cells contained mutations with respect to their germline counterparts, almost all of these mutations occurred before the clonal expansion of the tumor.
|
7579401 |
1995 |
Adult Diffuse Large B-Cell Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In five of the six unmutated CLLs, the DLBL clones evolved from CLL tumorclones and the VH genes expressed by DLBLs were also unmutated.
|
14671632 |
2004 |
Chronic Lymphocytic Leukemia
|
0.070 |
Biomarker
|
disease |
BEFREE |
We examined the immunoglobulin (Ig) heavy chain variable region genes (V(H) genes) used by leukemia cells of 1220 unrelated patients with chronic lymphocytic leukemia (CLL).
|
15217828 |
2004 |
Chronic Lymphocytic Leukemia
|
0.070 |
Biomarker
|
disease |
BEFREE |
We examined the chronic lymphocytic leukemia (CLL) cells of 2457 patients evaluated by the CLL Research Consortium (CRC) and found that 63 (2.6%) expressed immunoglobulin (Ig) encoded by the Ig heavy-chain-variable-region gene (IGHV), IGHV3-21.
|
18326815 |
2008 |
Lymphoma, Follicular
|
0.020 |
Biomarker
|
disease |
BEFREE |
The frequency of VH family use in FL was found to be similar to that reported for normal peripheral blood lymphocytes and is therefore also roughly proportional to VH family size.
|
1909196 |
1991 |
Mucosa-Associated Lymphoid Tissue Lymphoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Based on the CDR3 sequence amplified from each MALT lymphoma, individual tumor-specific primers were synthesized and used directly in the polymerase chain reaction (PCR) to analyze the sequences of their Ig heavy-chain variable region.
|
7579460 |
1995 |
Familial primary gastric lymphoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Based on the CDR3 sequence amplified from each MALT lymphoma, individual tumor-specific primers were synthesized and used directly in the polymerase chain reaction (PCR) to analyze the sequences of their Ig heavy-chain variable region.
|
7579460 |
1995 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Furthermore, this technological advance should be equally effective at identifying specific VH gene-expressing cells in other lymphoid malignancies, as well as in nonmalignant B cell disorders.
|
7883997 |
1995 |
DiGeorge Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
By chromosomal in situ hybridization and YAC identification, SLC7A4 was mapped to 22q11.2, the commonly deleted region of the velocardiofacial syndrome (VCFS, Shprintzen syndrome).
|
9598310 |
1998 |
Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In addition, human glioblastoma cells stably overexpressing a fusion protein between SLC7A4 and the enhanced green fluorescent protein (EGFP) did not exhibit an increased transport activity for l-arginine.
|
12049641 |
2002 |
Lymphoma
|
0.010 |
Biomarker
|
group |
BEFREE |
With one possible exception, none of these lymphoma VH sequences appear to represent any of the VH3 genes that may be preferentially used in the fetal repertoire.
|
1909196 |
1991 |
Shprintzen syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
By chromosomal in situ hybridization and YAC identification, SLC7A4 was mapped to 22q11.2, the commonly deleted region of the velocardiofacial syndrome (VCFS, Shprintzen syndrome).
|
9598310 |
1998 |
Adult Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In addition, human glioblastoma cells stably overexpressing a fusion protein between SLC7A4 and the enhanced green fluorescent protein (EGFP) did not exhibit an increased transport activity for l-arginine.
|
12049641 |
2002 |
Childhood Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In addition, human glioblastoma cells stably overexpressing a fusion protein between SLC7A4 and the enhanced green fluorescent protein (EGFP) did not exhibit an increased transport activity for l-arginine.
|
12049641 |
2002 |